HIV breakthrough? drug may let patients ditch daily meds
NCT ID NCT07145164
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called N-803 (IL-15) can train the immune system to control HIV without daily antiretroviral therapy. Twenty people with HIV on stable treatment will receive the drug or a placebo, then temporarily stop their HIV meds to see if the virus stays under control. The goal is to reduce or eliminate the need for lifelong daily pills.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCSF
San Francisco, California, 94044, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?